clebopride has been researched along with Fibrosis in 1 studies
clebopride: antidopaminergic; RN given refers to parent cpd; structure
Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Benedetto, P | 1 |
| Liakouli, V | 1 |
| Ruscitti, P | 1 |
| Berardicurti, O | 1 |
| Carubbi, F | 1 |
| Panzera, N | 1 |
| Di Bartolomeo, S | 1 |
| Guggino, G | 1 |
| Ciccia, F | 1 |
| Triolo, G | 1 |
| Cipriani, P | 1 |
| Giacomelli, R | 1 |
1 other study available for clebopride and Fibrosis
| Article | Year |
|---|---|
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
Topics: Adult; Antigens, CD; Antigens, Neoplasm; Benzamides; Cell Differentiation; Cell Proliferation; Cells | 2018 |